InhalPlus
InhalPlus develops a patented inhalation system to improve respiratory therapy in preterm infants.
$559.4K Pre Seed ·
Led by NBank Capital · Source: deutsche-startups.de
Funding history ↓Signals
Website registeredNov 14, 2023 (3 years old)
Funding rounds
- Pre Seed · $559.4K
NNBank Capital (lead)
Source: deutsche-startups.de - Website created
Founders and team
FW
Felix Wiegandt Founder
Investors
Similar Health and bio companies
CCelea Therapeutics$180M Series A · Jul 2026
DDuet$15M Series A · Nov 2026
SSkribe Medical$1.65M Pre Seed · Nov 2026
EEli Radiopharma$59.96M Series A · Nov 2026SSE3 Labs$30M Seed · Nov 2026
SSleep.ai$5.3M · Nov 2026
Other companies backed by NBank Capital
AAllogenetics$4.43M Seed · Sep 2026
BBioweg$19M Series A · Sep 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/inhalplus (get a free API key).